CBX Biosciences
  • Home
  • Our Technology
  • Our Products
  • Contact Us
  • More
    • Home
    • Our Technology
    • Our Products
    • Contact Us
CBX Biosciences
  • Home
  • Our Technology
  • Our Products
  • Contact Us

Rare Cannabinoids

CBG, CBC, CBDV, THCV...

Unique Therapeutic Properties
Focus on Rare Cannabinoids
Chemical structures of four cannabinoids.

While THC and CBD are well-known, more than 100 cannabinoids have been discovered from cannabis plant.

Focus on Rare Cannabinoids

Unique Therapeutic Properties
Focus on Rare Cannabinoids
Hemp seeds, powder, and oil on a wooden surface.

Our product line emphasizes rare cannabinoids, providing unique alternatives for therapeutic benefits beyond common options.

Unique Therapeutic Properties

Unique Therapeutic Properties
Unique Therapeutic Properties
Herbs, pine cones, and mortar with pestle on white surface.

Rare cannabinoids like CBG and CBN have distinct therapeutic benefits that set them apart from common cannabinoids like THC and CBD.

Non-Psychoactive Benefits

Non-Psychoactive Benefits
Unique Therapeutic Properties
Woman stressed with chaotic thoughts around her.

By excluding THC, we offer products that deliver therapeutic effects without the psychoactive side effects associated with traditional cannabis.

Therapeutic Applications

Non-Psychoactive Benefits
Therapeutic Applications

The unique properties of rare cannabinoids can be explored for various therapeutic applications, enhancing patient care.

CPG Market Opportunities

Non-Psychoactive Benefits
Therapeutic Applications

Understanding rare cannabinoids can lead to new market opportunities in the cannabis industry for innovative products.

CBX Biosciences

5681 Birney Avenue #202, University Endowment Lands, BC, Canada

+1 (236) 8688 CBX

Copyright © 2026 CBX Biosciences - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept